Indeed, CRISPR knockout studies have demonstrated that METTL13 was not an essential gene in normal cell lines but more likely to be essential in osteosarcoma, diffuse glioma, non-Hodgkin lymphoma, melanoma, and liposarcoma cell lines (DepMap: Cancer dependency map60,61). This evidence concerns the gene METTL13 and osteosarcoma.